Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study

Kiran Bhave; Aashiana Thiyam; Tejal Patel; Monisha Chavan; Shashank Desai

doi:10.5455/njppp.2022.12.08408202206092022

2024, Vol: 14, Issue: 4

14 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
20 / 09 / 2022

Natl J Physiol Pharm Pharmacol. 2022; 12(10): 1669-1674

doi: 10.5455/njppp.2022.12.08408202206092022

Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study

Kiran Bhave, Aashiana Thiyam, Tejal Patel, Monisha Chavan, Shashank Desai.

Abstract
Background: COVID-19 caused immense morbidity and mortality worldwide and was declared a pandemic on March 11, 2020, by the World Health Organization. Lack of effective treatments directed researchers to various interventional strategies, such as development of new drugs or vaccines, drug repurposing models, and AYUSH formulations, for prophylaxis and treatment of COVID-19.

Aim and Objectives: The information obtained from registered COVID-19 trials for the year 2020, will help to identify the various aspects for therapeutics and types of study designs used for achieving different objectives, so as to guide researchers for similar future projects.

Materials and Methods: A descriptive, observational study was conducted on COVID-19-related clinical trials registered in Clinical Trials Registry of India during calendar year 2020. The details were noted in a predesigned pro forma and evaluated.

Results: Of the 946 registered trials, majority were single center (82.76%), interventional (50.7%), randomized (73.1%), open-labeled (61.9%), and prospective in nature (96%). Our study revealed that 40.16% trials used modern medicine while 26.53% used AYUSH formulations. The psychological impact of COVID-19 pandemic was studied in 121 trials, of which 118 trials showed negative impact on the mental well-being.

Conclusion: Our study provides thorough insight about the on-going research in our country, especially about various drug repurposing strategies and government supported AYUSH interventions. This may act as a foundation for future investigators to identify any lacunae in the current studies, helping them to diversify their objectives accordingly, so as to encourage quality research in our country.

Key words: COVID-19; Coronavirus; COVID Trials; AYUSH

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kiran Bhave Articles by Aashiana Thiyam Articles by Tejal Patel Articles by Monisha Chavan Articles by Shashank Desai
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Bhave K, Thiyam A, Patel T, Chavan M, Desai S. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. Natl J Physiol Pharm Pharmacol. 2022; 12(10): 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Web Style

Bhave K, Thiyam A, Patel T, Chavan M, Desai S. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. https://www.njppp.com/?mno=107927 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.08408202206092022

AMA (American Medical Association) Style

Bhave K, Thiyam A, Patel T, Chavan M, Desai S. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. Natl J Physiol Pharm Pharmacol. 2022; 12(10): 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Vancouver/ICMJE Style

Bhave K, Thiyam A, Patel T, Chavan M, Desai S. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(10): 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Harvard Style

Bhave, K., Thiyam, . A., Patel, . T., Chavan, . M. & Desai, . S. (2022) Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. Natl J Physiol Pharm Pharmacol, 12 (10), 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Turabian Style

Bhave, Kiran, Aashiana Thiyam, Tejal Patel, Monisha Chavan, and Shashank Desai. 2022. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (10), 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Chicago Style

Bhave, Kiran, Aashiana Thiyam, Tejal Patel, Monisha Chavan, and Shashank Desai. "Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

MLA (The Modern Language Association) Style

Bhave, Kiran, Aashiana Thiyam, Tejal Patel, Monisha Chavan, and Shashank Desai. "Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study." National Journal of Physiology, Pharmacy and Pharmacology 12.10 (2022), 1669-1674. Print. doi:10.5455/njppp.2022.12.08408202206092022

APA (American Psychological Association) Style

Bhave, K., Thiyam, . A., Patel, . T., Chavan, . M. & Desai, . S. (2022) Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: A descriptive study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (10), 1669-1674. doi:10.5455/njppp.2022.12.08408202206092022

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272